Can intravesical prostatic protrusion predict bladder outlet obstruction even in men with good flow?  by Lee, Alvin et al.
Asian Journal of Urology (2016) 3, 39e43HOSTED BY Available online at www.sciencedirect.com
ScienceDirect
journal homepage: www.elsevier .com/locate/ajurORIGINAL ARTICLECan intravesical prostatic protrusion predict
bladder outlet obstruction even in men with
good flow?
Alvin Lee a, Han Jie Lee a, Kok Bin Lim b, Hong Hong Huang a,
Henry Ho a,*, Keong Tatt Foo aa Department of Urology, Singapore General Hospital, Singapore
b Urology Centre, Raffles Hospital, SingaporeReceived 5 July 2015; received in revised form 30 August 2015; accepted 16 September 2015








Peer review under responsibility o
http://dx.doi.org/10.1016/j.ajur.2015
2214-3882/ª 2016 Editorial Office of A
the CC BY-NC-ND license (http://creaAbstract Objective: Men with benign prostate hyperplasia (BPH) with good urinary flow may
still have bladder outlet obstruction (BOO). Intravesical prostatic protrusion (IPP) has been
shown to be able to predict BOO. We aim to investigate the use of IPP to predict BOO in
men with good urinary flow.
Methods: One hundred and fourteen consecutive men (>50 years old) presenting with lower
urinary tract symptoms suggestive of BPH were recruited in 2001 and 2002. They were evalu-
ated with serum prostate specific antigen (PSA), uroflowmetry and transabdominal ultrasound
measurement of IPP and prostate volume (PV). Pressure-flow urodynamic studies were per-
formed on all men and BOO was defined by BOO index > 40. Men with Qmax  12.0 mL/s were
considered to have good flow.
Results: Among the 114 men, 61 patients had good urinary flow. Their median age, PV and Qmax
were 66 years, 32.9 mm3 and 14.5 mL/s respectively. 14/61 (23.0%) patients had BOO and their
distribution of IPP were as follows: Grade 1 e 0/20 (0%) obstructed, Grade 2 e 6/22 (27.3%)
and Grade 3 e 8/19 (42.1%). Sensitivity of Grade 2/3 IPP for BOO was 100% while specificity
of Grade 3 IPP was 76.6%. The area-under-curve (AUC) for IPP was greater than that for PV
(0.757 vs. 0.696).
Conclusion: Even in men with good flow, high grades of IPP were more likely to have BOO and
hence, may be a useful adjunct to predict BOO.
ª 2016 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier B.V. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).om.sg (H. Ho).
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Benign prostate enlargement (BPE) is a common cause of
bladder outlet obstruction with increasing incidence in men
over 50 years of age [1]. Urodynamic study is the interna-
tional gold standard for diagnosis of bladder outlet
obstruction (BOO), but its routine use has been limited by
its invasive nature [2]. Currently, several markers identified
to be of useful significance in the evaluation of BOO include
uroflowmetry, post-void residual urine (PVR), prostate
volume (PV), prostate-specific antigen (PSA) and intra-
vesical prostatic protrusion (IPP) [3,4].
Uroflowmetry studies have become established as a non-
invasive and routine investigation in men suspected to have
BPE. However, peak urinary flow rate (Qmax) has limited
sensitivity and specificity for BOO depending on the cut-off
used [5]. A threshold value of Qmax of 10 mL/s has good
specificity but poor sensitivity for BOO while a threshold
value of Qmax of 15 mL/s has good sensitivity but poor
specificity [6].
Anatomical configuration of the prostate in the form of
IPP has been proven to have good correlation to BOO [2,3].
Studies have shown that the grade of IPP is able to predict
success of trial without catheter [7,8], efficacy of a-blocker
therapy [9] and clinical progression [10]. In this study, we
aim to investigate the use of IPP to predict BOO in men with
good urinary flow rate.
2. Patients and methods
From November 2001 to November 2002, 114 consecutive
men older than 50 years presenting with lower urinary tract
symptoms (LUTS) suggestive of BPE were recruited. Their
evaluation included digital rectal examination, uro-
flowmetry (Qmax) and serum PSA measurement.
Transabdominal ultrasound scan by a single operator
(F.K.T.) measured the IPP, PV and PVR. The method of
measurement for IPP and grading system was as previously
reported [11]. The degree of IPP was measured in milli-
meters perpendicularly from the intravesical edge of the
prostate to the base of the bladder in the mid-sagittalFigure 1 Measurement of intravesical prostatic protrusion (IPP). T
the base of the bladder in the sagittal view using transabdominal ulplane, by transabdominal ultrasound (Fig. 1) [12]. The
extent of IPP was classified as Grade 1 Z 5 mm or less,
Grade 2 Z greater than 5e10 mm and Grade 3 Z greater
than 10 mm. As a general rule, the IPP is to be measured
with the bladder slightly distended with 100e200 mL of
urine [11]. The exclusion criteria included previous lower
urinary tract or pelvic surgery, previous pelvic trauma, ra-
diation therapy, diabetic cystopathy or neurological
bladder with voiding dysfunction. Patients with raised PSA
underwent transrectal ultrasound guided prostate biopsy to
exclude malignancy before inclusion. Those with incom-
plete datasets were excluded from statistical analysis.
Pressure-flow urodynamic studies (UDS) were performed
on all patients according to the ICS recommendations. The
extent of BOO was calculated using the BOO index (BOOI of
>40 indicates definite obstruction, 20e40 is equivocal and
<20 indicates no obstruction).
Complete datasets of IPP and BOOIwere available in 112 of
the patients. In our study, we are looking at patients with
Qmax 12.0mL/swhichwewill be referencing as a good flow.
Statistical analysis was performed using SPSS version
(IBM, Chicago, IL, USA). Any significant differences in me-
dian were analysed using KruskaleWallis test while corre-
lations were analysed using Spearman’s rho (rs).
Differences are significant if p < 0.05. Local Domain Spe-
cific Review Board ethics approval was granted (Reference:
2012/311/D).
3. Results
Sixty-one patients had Qmax  12.0 mL/s. Their median age
was 66 years (range: 53e83 years). The median Qmax was
14.5 mL/s (range: 12.1e30.7 mL/s), median PVR was
49.4 mL (range: 8e120 mL), and median PV was 32.9 mm3.
Their IPP grade is distributed as follows: 20 had Grade 1 IPP
(0e5 mm), 22 had Grade 2 IPP (6e10 mm) and 19 had Grade
3 IPP (>10 mm). PV, detrusor pressure (at peak flow) and
BOOI were all significantly different between grades 1 to 3
IPP (Table 1).
Of the patients with Qmax  12.0 mL/s, only 14/61
(23.0%) of them had BOO, 28/61 (45.9%) had equivocal BOOIhe vertical distance between the point of highest protrusion to
trasonography. Reproduced with permission of the authors [12].
Table 1 Patient characteristics and urodynamic parameters based on IPP grade.
Parameters IPP grade Total (n Z 61) p-Value
Grade 1 (n Z 20) Grade 2 (n Z 22) Grade 3 (n Z 19)
Age (year)a 63 (56e66)* 67 (59e71)* 72 (65e76)* 66 (58e73) 0.017
Qmax (mL/s)
a 14.7 (12.5e20.0) 14.5 (13.2e20.0) 14.5 (13.5e17.7) 14.5 (13.4e18.6) 0.962
PV (mm3)a 20.5 (16.0e26.5)* 29.4 (25.8e45.8)* 51.8 (43.6e75.0)* 32.9 (22.2e49.3) <0.001*
PVR (mL)a 37.0 (23.5e61.8) 55.7 (33.7e72.5) 49.6 (34.3e66.4) 49.4 (30.5e68.2) 0.175
Pdet at peak flow (cmH2O)
a 43.5 (29.5e53.8)* 51.0 (36.5e70.5)* 67.0 (60.0e75.0)* 54.0 (36.0e68.0) <0.001*
BOOIa 5.5 (3.0e25.9)* 18.9 (0.5e41.0)* 35.2 (23.8e46.0)* 23.8 (1.1e37.7) 0.001*
Detrusor instability, n (%) 8 (40.0) 12 (54.5) 10 (52.6) 30 (49.2) 0.601
*p < 0.05, KruskaleWallis test between the 3 grades of IPP.
a Values shown as median (interquartile range). BOOI, bladder outlet obstruction index; IPP, intravesical prostatic protrusion; PV,
prostate volume; PVR, post void residual urine; Qmax, peak urinary flow rate.
IPP and BOO in men with good flow 41and 19/61 (31.1%) had no BOO. BOO was seen in 8/19
(42.1%) of Grade 3 IPP prostates and in none of those with
Grade 1 IPP (Table 2). Table 3 depicts the sensitivity,
specificity, positive and negative predictive value of higher
grades of IPP in identifying BOO.
There was good positive correlation between IPP and PV.
The correlation coefficient between IPP and PV is 0.747
(P < 0.001). Both PV and IPP were positively correlated to
BOOI. However, IPP had better correlation (rs Z 0.497,
P < 0.001) (Fig. 2A) than PV (rsZ 0.318, PZ 0.013) to BOOI
(Fig. 2B). This trend was also observed between PV and IPP
with BOO (BOOI > 40) (rs Z 0.280, P Z 0.030 and
rs Z 0.391, P Z 0.002, respectively). Based on receiver-
operator curves (ROC), area-under-curve (AUC) for IPP
was greater than the AUC for PV (0.757, P Z 0.005 vs.
0.696, P Z 0.031) (Fig. 3).
4. Discussion
IPP in BPH occurs as the prostate enlarges into the bladder
along the plane of least resistance, resulting in various
anatomical configurations that were recognised in gross
specimens by Randall in the early 20th century [13]. IPP can
be caused by an enlarging median and/or lateral lobes of
the prostate. It is postulated that IPP causes distortion of
the bladder neck which then disrupts laminar flow and
funneling, leading to dynamic obstruction [12]. The mea-
surement of IPP via transabdominal ultrasound is simple,
non-invasive and can provide useful information on BOO
[10], success of trial without catheter [7,8] and clinical












Grade 1 0 (0.0) 13 (65.0) 7 (35.0) 20
Grade 2 6 (27.3) 11 (50.0) 5 (22.7) 22
Grade 3 8 (42.1) 4 (21.1) 7 (36.8) 19
Total 14 (23.0) 28 (45.9) 19 (31.1) 61
BOOI, bladder outlet obstruction index; IPP, intravesical pros-
tatic protrusion; UDS, urodynamic studies.that IPP is a better predictor of BOO, compared to PV and
PSA [3]. While IPP has been proven to be a good predictor of
obstruction [4], this is the first study to our knowledge that
endeavored to investigate the use of IPP to predict BOO in
men with good urinary flow.
UDS remains the gold standard of diagnosis of BOO [2].
However, its use is limited by its invasive nature and con-
fers undesirable morbidity such as gross hematuria, urinary
retention, urinary tract infection and pain [14]. Uro-
flowmetry is another useful clinical parameter which can
help in the clinical evaluation of BPH. It is a function of
bladder contractility and bladder outlet resistance and
thereby only measure the functional status of the lower
urinary tract, rather than being a direct marker of
obstruction. Reynard et al. [6] proposed the use of 10 mL/s
as a cut-off to reduce the number of unobstructed men
undergoing prostatectomy, such that the results of surgery
could be improved by selecting a threshold which is highly
specific and with a high positive predictive value for BOO.
However, at this cut-off, sensitivity is low at merely 47%,
meaning that 53% of men with BOO have flow rates above
10 mL/s. Bladder outlet resistance can be overcome at
higher detrusor pressures to produce good flow, which
could possibly explain why men with obstruction can still
have relatively good urinary flow.
Despite having good flow, 23.0% of the men in our study
still had BOO. In our analysis of men with good flow, we
found that IPP still had better correlation to both BOO and
BOOI compared to PV. Furthermore, the AUC for IPP was
greater than PV, suggesting that it is a better predictor of
BOO. Higher grades of IPP (Grade 2/3) have good sensitivityTable 3 Evaluation of accuracy of IPP in identifying BOO.
Statistics Grade 2/3 IPP Grade 3 IPP
Sensitivity 100 (76.7e100) 57.1 (28.9e82.2)
Specificity 42.6 (28.3e57.8) 76.6 (62.0e87.7)
PPV 34.2 (20.1e50.6) 42.1 (20.3e66.5)
NPV 100 (83.0e100) 85.7 (71.5e94.5)
Values are presented as % with 95%CI in parentheses. BOO,
bladder outlet obstruction; IPP, intravesical prostatic protru-
sion; PPV, positive predictive value; NPV, negative predictive
value.
Figure 2 (A) Scatter plot of relationship between BOOI and IPP (rs = 0.497) and (B) scatter plot showing relationship between
BOOI and PV (rs Z 0.318). BOOI, bladder outlet obstruction index; PV, prostate volume; IPP, intravesical prostatic protrusion.
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(100%). Grade 3 IPP also has good specificity for BOO
(76.6%). This present study suggests that IPP could be a
useful non-invasive adjunct to predict BOO in men with
relatively good urinary flow. Identification of high grade
(Grade 2/3) IPP as an anatomical, causative factor may help
identify BOO in these men whose bladders are able to
produce greater detrusor pressures to overcome infraves-
ical obstruction. In clinical practice, urologists may assume
that patients with good flow have no BOO. However, we
want to highlight that in this group of patients, a significant
IPP may confer a higher risk of having BOO and may warrant
closer observation with possibly a lower threshold for
intervention.
While UDS is clearly the only reliable method by which
BOO can be diagnosed, our study shows that Qmax and IPP
can provide good improvement in diagnostic power. In
patients with Grade 1 IPP and good flow, benign prostate
obstruction is very unlikely to be a cause of the patients’
LUTS and hence clinicians should perform otherFigure 3 Receicer-operator characteristic curves of IPP and
PV for BOO. BOO, bladder outlet obstruction; PV, prostate
volume; IPP, intravesical prostatic protrusion.investigations such as cystoscopy and urodynamic studies
before considering invasive management for their pa-
tients. Furthermore, clinicians will be better able to
identify and select men with BOO to undergo surgical
resection of prostate, which could potentially result in
more satisfactory post-operative outcomes [15]. Other
non-invasive parameters such as detrusor wall thickness
[16,17], prostatic urethral angle [18] and ultrasound-
estimated bladder weight [19] have also been shown to
predict BOO. However, most of these measurements are
based on the consequences of BOO. An attractive quality
of transabdominal ultrasonographic measurement of IPP is
that it allows for evaluation of the prostate anatomy as a
causative and predictive factor of bladder outlet
obstruction before the onset of sequelae of BOO such as
detrusor hypertrophy, bladder trabeculation with diver-
ticulum as well as hydronephrosis with obstructive urop-
athy [14].
Although our study is prospective and utilises UDS in the
diagnosis of BOO, it is limited by its small sample size. IPP
measurements via transabdominal ultrasound are affected
by bladder volume at the time of measurement [11]. Un-
fortunately, we did not capture the bladder volume at
which the IPP was measured in our analysis. However, we
do have a general practice of measuring IPP when the
bladder is sufficiently distended with about 100e200 mL of
urine and this results in only minimal differences in the IPP
measured [11]. A more significant source of error would be
that of inter-observer variability in measurement. We have
already reduced this variability by having a single, experi-
enced operator to perform the measurements. Uro-
flowmetry findings also differ between voids and ideally, we
could perform analysis using readings from multiple voids
[20]. Symptom scores have been shown to correlate poorly
with BOO by several studies and hence, this analysis was
omitted [4,21e28].
In our study, we endeavoured to examine the use of IPP
in men with Qmax  12.0 mL/s in predicting BOO. Even with
relatively good urinary flow, men with higher grades of IPP
are more likely to have BOO. Conversely, patients with no
or low grade IPP with good flow are unlikely to have BOO.
Our present study provides more evidence that IPP
measured via transabdominal ultrasound is a useful, non-
IPP and BOO in men with good flow 43invasive adjunct in diagnosis, stratification and manage-
ment of BPE in men.
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